Abstract 17973: Possible Roles of Myocardial Infiltration of Inflammatory Cells for the Development of Ventricular Fibrosis in Patients With DCM

Takafumi Nakayama(National Cerebral and Cardiovascular Center), Toshihisa Anzai(Hokkaido University), Hideaki Kanzaki(National Cerebral and Cardiovascular Center), Hisao Ogawa(Kumamoto University Hospital), Nobuyuki Ohte(Nagoya City University), Satoshi Yasuda(National Institute of Health Sciences), Tetsuro Yokokawa(Fukushima Medical University), Taka‐aki Matsuyama(National Cerebral and Cardiovascular Center), Yoshihiko Ikeda(National Cerebral and Cardiovascular Center), Toshiyuki Nagai(Hokkaido University), Yasuo Sugano(keiyu Hospital), Hiroo UEDA, Keiko Ogo(National Cerebral and Cardiovascular Center)
Circulation
November 14, 2017
Cited by 0

Related Papers

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
|The Lancet|2017|881
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755